Holdings of Progeny 3, Inc.
28 declared positions · as of Mar 31, 2026
Original filing · Ten largest lines: 62.5 % of the equity sleeve
Sector breakdown
- Financials 11.8 %
- Funds 10.4 %
- Materials 4.6 %
- Energy 4.4 %
- Consumer discretionary 3.6 %
- Unattributed 65.2 %
Titelia classification, company by company. The unattributed share stays visible.
Currency breakdown
The quoted currency of each line, as declared.
Country breakdown
- US 99.8 %
- FR 0.1 %
- DK 0.1 %
Shares computed on the equity sleeve.
| Rank | Country | Lines | Value | Share |
|---|
| 1 | US | 26 | 1.5B $ | 99.82 % |
| 2 | FR | 1 | 1.4M $ | 0.09 % |
| 3 | DK | 1 | 1.2M $ | 0.08 % |
Positions
| Rank | Company | Shares | Value | Weight |
|---|
| 1 | Interactive Brokers Group Inc | 2,195,640 | 147.3M $ | |
| 2 | API Group Corp | 3,540,787 | 143.5M $ | |
| 3 | TIC Solutions Inc | 15,323,105 | 100.8M $ | |
| 4 | iShares Core S&P 500 ETF | 139,069 | 90.8M $ | |
| 5 | Alliance Resource Partners LP | 3,229,764 | 89.3M $ | |
| 6 | SS&C Technologies Holdings Inc | 1,258,900 | 85.1M $ | |
| 7 | Martin Marietta Materials Inc | 113,150 | 66.6M $ | |
| 8 | EQT Corp | 1,009,400 | 64.2M $ | |
| 9 | Enterprise Products Partners LP | 1,683,631 | 63.7M $ | |
| 10 | Vanguard S&P 500 ETF | 103,300 | 61.7M $ | |
| 11 | MPLX LP | 1,015,966 | 58M $ | |
| 12 | Solstice Advanced Materials Inc | 731,100 | 55.7M $ | |
| 13 | Daktronics Inc | 2,746,408 | 53.7M $ | |
| 14 | Energy Transfer LP | 2,743,907 | 53M $ | |
| 15 | Amazon.com Inc | 250,100 | 52.1M $ | |
| 16 | Sixth Street Specialty Lending Inc | 2,476,398 | 45.5M $ | |
| 17 | PriceSmart Inc | 272,100 | 41M $ | |
| 18 | Ares Capital Corp | 2,224,728 | 40.1M $ | |
| 19 | Natural Resource Partners L.P. | 312,523 | 37.8M $ | |
| 20 | PAR Technology Corp | 2,170,808 | 28.9M $ | |
| 21 | Pool Corp | 140,000 | 28.3M $ | |
| 22 | Berkshire Hathaway Inc | 53,239 | 25.5M $ | |
| 23 | Blackstone Secured Lending Fund | 772,156 | 18.3M $ | |
| 24 | Warrior Met Coal Inc | 54,235 | 5.1M $ | |
| 25 | Abivax SA | 12,240 | 1.4M $ | |
| 26 | Vaxcyte Inc | 23,300 | 1.4M $ | |
| 27 | Ascendis Pharma A/S | 5,230 | 1.2M $ | |
| 28 | Crinetics Pharmaceuticals Inc | 24,000 | 871.7K $ | |